Publication:
Secondary arterial hypertension: when, who, and how to screen?

cris.virtualsource.author-orcid7efa4f9e-9a50-477d-ba95-eee46063f540
cris.virtualsource.author-orcid3052ae31-b9ca-4adc-b818-168d118adc57
datacite.rightsopen.access
dc.contributor.authorRimoldi, Stefano
dc.contributor.authorScherrer, Urs
dc.contributor.authorMesserli, Franz H
dc.date.accessioned2024-10-14T16:09:46Z
dc.date.available2024-10-14T16:09:46Z
dc.date.issued2014
dc.description.abstractSecondary hypertension refers to arterial hypertension due to an identifiable cause and affects ∼5-10% of the general hypertensive population. Because secondary forms are rare and work up is time-consuming and expensive, only patients with clinical suspicion should be screened. In recent years, some new aspects gained importance regarding this screening. In particular, increasing evidence suggests that 24 h ambulatory blood pressure (BP) monitoring plays a central role in the work up of patients with suspected secondary hypertension. Moreover, obstructive sleep apnoea has been identified as one of the most frequent causes. Finally, the introduction of catheter-based renal denervation for the treatment of patients with resistant hypertension has dramatically increased the interest and the number of patients evaluated for renal artery stenosis. We review the clinical clues of the most common causes of secondary hypertension. Specific recommendations are given as to evaluation and treatment of various forms of secondary hypertension. Despite appropriate therapy or even removal of the secondary cause, BP rarely ever returns to normal with long-term follow-up. Such residue hypertension indicates either that some patients with secondary hypertension also have concomitant essential hypertension or that irreversible vascular remodelling has taken place. Thus, in patients with potentially reversible causes of hypertension, early detection and treatment are important to minimize/prevent irreversible changes in the vasculature and target organs.
dc.description.numberOfPages10
dc.description.sponsorshipUniversitätsklinik für Kardiologie
dc.identifier.doi10.7892/boris.43125
dc.identifier.pmid24366917
dc.identifier.publisherDOI10.1093/eurheartj/eht534
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/114336
dc.language.isoen
dc.publisherOxford University Press
dc.relation.ispartofEuropean Heart Journal
dc.relation.issn0195-668X
dc.relation.organizationDCD5A442BB15E17DE0405C82790C4DE2
dc.subjectArterial hypertension
dc.subjectObstructive sleep apnoea
dc.subjectPheochromocytoma
dc.subjectPrimary aldosteronism
dc.subjectRenal artery stenosis
dc.subjectSecondary hypertension
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleSecondary arterial hypertension: when, who, and how to screen?
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage1254
oaire.citation.issue19
oaire.citation.startPage1245
oaire.citation.volume35
oairecerif.author.affiliationUniversitätsklinik für Kardiologie
oairecerif.author.affiliationUniversitätsklinik für Kardiologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.date.licenseChanged2019-10-23 06:14:10
unibe.description.ispublishedpub
unibe.eprints.legacyId43125
unibe.journal.abbrevTitleEur Heart J
unibe.refereedtrue
unibe.subtype.articlereview

Files

Original bundle
Now showing 1 - 1 of 1
Name:
1245.full.pdf
Size:
1.12 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections